• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

采用三相序贯药物治疗策略的门诊抑郁症患者(无)反应的预测因素。

Predictors of (non-) response in depressed outpatients treated with a three-phase sequential medication strategy.

作者信息

Hoencamp E, Haffmans P M, Duivenvoorden H, Knegtering H, Dijken W A

机构信息

Out-patient Department, Psychiatric Centre Bloemendaal, The Hague, The Netherlands.

出版信息

J Affect Disord. 1994 Aug;31(4):235-46. doi: 10.1016/0165-0327(94)90099-x.

DOI:10.1016/0165-0327(94)90099-x
PMID:7989638
Abstract

The predictive value of eight domains or sets of variables including sociodemographic aspects, premorbid history, symptomatology, personality, social and diagnostic data are evaluated in depressed outpatients with a Hamilton Rating Scale for Depression (HRSD) score of at least 14. Patients were treated using a three-phase sequential treatment strategy. Of the 119 patients, 88 completed the trial. The HRSD-score at the end of phases I, II or III was used as an outcome measure. Patients with an initially high HRSD-score and an obsessive-compulsive personality had a greater chance of recovery, while patients with somatization and a passive-aggressive personality had less of a chance of recovery. Variables involving psychiatric history, premorbid history or symptomatology of the depression, were not significantly related to outcome. The endogenous/non-endogenous distinction was not a predictor of response.

摘要

对包括社会人口学特征、病前史、症状学、人格、社会和诊断数据在内的八个领域或变量集的预测价值进行了评估,研究对象为汉密尔顿抑郁量表(HRSD)评分至少为14分的门诊抑郁症患者。患者采用三阶段序贯治疗策略进行治疗。119例患者中,88例完成了试验。将I期、II期或III期结束时的HRSD评分用作结局指标。初始HRSD评分高且具有强迫性人格的患者康复机会更大,而有躯体化症状且具有被动攻击型人格的患者康复机会较小。涉及精神病史、病前史或抑郁症症状学的变量与结局无显著相关性。内源性/非内源性的区分不是反应的预测指标。

相似文献

1
Predictors of (non-) response in depressed outpatients treated with a three-phase sequential medication strategy.采用三相序贯药物治疗策略的门诊抑郁症患者(无)反应的预测因素。
J Affect Disord. 1994 Aug;31(4):235-46. doi: 10.1016/0165-0327(94)90099-x.
2
Brofaromine versus lithium addition to maprotiline. A double-blind study in maprotiline refractory depressed outpatients.溴法罗明与锂盐联合马普替林的比较。一项针对马普替林难治性门诊抑郁症患者的双盲研究。
J Affect Disord. 1994 Mar;30(3):219-27. doi: 10.1016/0165-0327(94)90082-5.
3
Brofaromine vs. maprotiline plus lithium in treatment-resistant depressed outpatients.
Psychiatry Res. 1991 Mar;36(3):333-5. doi: 10.1016/0165-1781(91)90032-k.
4
A Canadian multicentre placebo-controlled study of a fixed dose of brofaromine, a reversible selective MAO-A inhibitor, in the treatment of major depression.
J Affect Disord. 1994 Oct;32(2):105-14. doi: 10.1016/0165-0327(94)90068-x.
5
Is there any specific personality disorder or personality disorder cluster that worsens the short-term treatment outcome of major depression?是否存在任何特定的人格障碍或人格障碍群组会使重度抑郁症的短期治疗结果恶化?
Acta Psychiatr Scand. 1993 Nov;88(5):342-9. doi: 10.1111/j.1600-0447.1993.tb03470.x.
6
Dose escalation vs. continued doses of paroxetine and maprotiline: a prospective study in depressed out-patients with inadequate treatment response.帕罗西汀和马普替林剂量递增与持续给药对比:对治疗反应欠佳的门诊抑郁症患者的一项前瞻性研究
Acta Psychiatr Scand. 1997 Apr;95(4):288-96. doi: 10.1111/j.1600-0447.1997.tb09634.x.
7
Transdermal selegiline in major depression: a double-blind, placebo-controlled, parallel-group study in outpatients.透皮司来吉兰治疗重度抑郁症:一项针对门诊患者的双盲、安慰剂对照、平行组研究。
Am J Psychiatry. 2002 Nov;159(11):1869-75. doi: 10.1176/appi.ajp.159.11.1869.
8
Brofaromine in non-endogenous major depressed inpatients--results of a preliminary dose-finding trial versus tranylcypromine.溴法罗明治疗非内源性重度抑郁住院患者——与反苯环丙胺对比的初步剂量探索试验结果
Pharmacopsychiatry. 1994 Jul;27(4):152-8. doi: 10.1055/s-2007-1014296.
9
A randomized controlled trial of duloxetine versus placebo in the treatment of nonmajor chronic depression.度洛西汀与安慰剂治疗非重症慢性抑郁症的随机对照试验。
J Clin Psychiatry. 2012 Jul;73(7):984-91. doi: 10.4088/JCP.11m07230.
10
A double-blind randomized placebo-controlled study of the efficacy and safety of pirlindole, a reversible monoamine oxidase A inhibitor, in the treatment of depression.一项关于可逆性单胺氧化酶A抑制剂匹克隆朵治疗抑郁症的疗效及安全性的双盲随机安慰剂对照研究。
Acta Psychiatr Scand. 1996 Dec;94(6):404-10. doi: 10.1111/j.1600-0447.1996.tb09881.x.

引用本文的文献

1
Using patient self-reports to study heterogeneity of treatment effects in major depressive disorder.利用患者自我报告研究重度抑郁症治疗效果的异质性。
Epidemiol Psychiatr Sci. 2017 Feb;26(1):22-36. doi: 10.1017/S2045796016000020. Epub 2016 Jan 26.
2
Are multiple physical symptoms a poor prognostic factor or just a marker of depression severity? Secondary analysis of the GenPod trial.多种躯体症状是不良预后因素还是仅仅是抑郁严重程度的一个指标?GenPod试验的二次分析。
J Affect Disord. 2014 Jul;163:40-6. doi: 10.1016/j.jad.2014.03.051. Epub 2014 Apr 4.
3
What moderator characteristics are associated with better prognosis for depression?
哪些调节者特征与抑郁症的更好预后相关?
Neuropsychiatr Dis Treat. 2005 Mar;1(1):51-7. doi: 10.2147/nedt.1.1.51.52298.
4
Ratings of early major depressive disorder symptom change during a brief psychiatric hospitalization.
Psychiatr Q. 2005 Spring;76(1):33-48. doi: 10.1007/s11089-005-5579-x.